has announced it has received FDA clearance for its new Age-Defying Laser
, which will launch early 2014.
Utilizing a proprietary version of the same non-ablative fractional laser technology used by dermatologists and plastic surgeons in-office, the Age-Defying Laser
is clinically proven to treat multiple signs of facial aging.
"The Age-Defying Laser represents a major breakthrough that allows consumers to safely and effectively use professional technology to get dramatic anti-aging results at home," stated Nicole Landberg, VP/GM, Americas & Europe.
Landberg continues, "According to the American Society of Plastic Surgeons, in-office fractional laser therapy has skyrocketed in the last decade and is now widely accepted as the gold standard for treating fine lines, wrinkles and discoloration with minimal downtime. We are pleased to make this effective, safe and innovative technology available to a much broader group of women."
In a series of clinical studies, independent dermatologists evaluated skin characteristics before and after use of the Age-Defying Laser and observed significant improvement in wrinkles and uneven texture.
In addition, 76% of users reported meaningful reduction in fines line and wrinkles and 95% of users noticed smoother skin and an improvement in overall appearance. Users reported visible results in as few as two weeks, with optimal results occurring for most users in eight weeks.
See more: Tria's packaging design.